Connect with us

Hi, what are you looking for?


Modern Trials Aims to Capitalize On Clinical Trial Market

Modern Trials

Miami based company Modern Trials is looking to capitalize on the big money market of medical trials, and a contract research industry that sees medical companies spending around $100 billion a year to find patients for clinical trials.

The trials can reportedly cost around $50 million each and there can be around 70,000 active trials ongoing within the United States at a given time.

Modern Trials founder Chris Ochner noticed an issue in this space based on his two decades worth of experience in the research and clinical trial niche, and his personal experience. Ochner had his own challenges when trying to connect his mother with a clinical trial.

“I thought, no problem, I’ll get this done in 20 minutes” Ochner said, according to Refresh Miami. “I spent a month and couldn’t find a trial for my own mother. That’s when I realized that this process is broken.”

Modern Trials, which was founded in 2019, is currently completing its proof of concept stage and has been entirely bootstrapped and there are plans currently for a full product launch within the next several months.

Ochner has been excited to continue building the company in Miami.

“It’s been phenomenal here” he said of South Florida. “This momentum is such an exciting thing to see, and there’s so much willingness to help.”


You May Also Like


AutoLeadStar, which is the Jerusalem based marketing and customer data startup for auto dealerships announced that they have raised a $40 million growth round,...


Miami-based digital media startup VentureKite, which buys and grows profitable websites, has officially announced that they have successfully closed a $30 million credit facility...


Miami based startup Grip has officially announced that they have raised $2 million in a pre-seed funding round that was backed by firms such...


Miami fintech unicorn Pipe is undergoing some massive changes, as the three co-founders of the company are officially stepping down from their executive roles...